Challenges in Managing an Ischemic Stroke in a Child with Homozygous SS Sickle Cell Disease Associated with Cerebral Palsy: A Case Report

  • Muriel Amon Tanoh Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Rosette Boundjike Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Nancy Tanya De-Souza Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Cedric Valery Kadjo Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Mody Kone Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Constance Yapo-Ehounoud Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Ismaila Diakite Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Christian Tanoh Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Evelyne Aka Diarra Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
  • Berthe Assi Félix Houphouët Boigny University, Abidjan, Côte d’Ivoire
Keywords: Stroke, Sickle cell anemia, Exchange transfusion, Transcranial Dopplerq, Côte d’Ivoire

Abstract

Introduction: Ischemic stroke is one of the most frequent complications of sickle cell disease (SCD) and may be associated with cognitive impairment. These two neurological manifestations can coexist in the same patient. Objective: To report a case of ischemic stroke and cognitive delay in a child with homozygous SS sickle cell disease. Case Report: We describe a 5-year and 8-month-old boy with homozygous SS sickle cell disease and epilepsy, non-compliant with his antiepileptic treatment, admitted for seizures that had progressively worsened over two months. A diagnosis of complicated major sickle cell syndrome was made. Discussion: The management of neurovascular, epileptic, and cognitive complications in this patient with cerebral palsy and sickle cell disease required evaluating the risk of severe anemia and stratifying the likelihood of stroke recurrence. Conclusion: Managing major sickle cell syndrome associated with neurovascular, epileptic, and cognitive complications in a child with cerebral palsy requires adherence to current evidence-based recommendations.

Downloads

Download data is not yet available.

PlumX Statistics

References

1. Tshilolo L, Tomlinson G, Williams TN et al. Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa. N Engl J Med. 2019;380(2):121–131.
2. Kirkham FJ, Lagunju IA. Epidemiology of stroke in sickle cell disease. J Clin Med. 2021;10(18):4232.
3. Mazumdar M, Heeney MM, Sox CM, Lieu TA. Preventing stroke among children with sickle cell anemia: an analysis of strategies involving transcranial Doppler testing and chronic transfusion. Pediatrics. 2007;120(4):e1107–e1116.
4. Abdullahi SU, Ijei IP, Galadanci NA et al. Hydroxyurea for primary stroke prevention in children with sickle cell anemia in Nigeria (SPRING): A double-blind, randomized, phase 3 trial. Lancet Haematol. 2022;9(1):e26–e37.
5. John CC et al. Hydroxyurea dose escalation for children with sickle cell anemia in sub-Saharan Africa. N Engl J Med. 2020;382(26):2524–2533.
6. Kakooza-Mwesige A, Andrews C, Peterson S et al. Prevalence of cerebral palsy in Uganda: A population-based study. Lancet Glob Health. 2017;5(12):e1275–e1282.
7. Lagunju IA, Brown BJ, Sodeinde OO. Chronic neurological complications of childhood sickle cell disease: A Nigerian experience. Afr Health Sci. 2014;14(2):397–405.
8. Moustapha N. Pediatric stroke: recent updates. Rev Neurol. 2021;177:S147.
9. Grosse SD, Odame I, Atrash HK et al. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6 Suppl 4):S398–S405.
10. World Health Organization (WHO). Epilepsy: A public health imperative. Geneva: WHO; 2019.
Published
2025-11-30
How to Cite
Amon Tanoh, M., Boundjike, R., Tanya De-Souza, N., Valery Kadjo, C., Kone, M., Yapo-Ehounoud, C., Diakite, I., Tanoh, C., Aka Diarra, E., & Assi, B. (2025). Challenges in Managing an Ischemic Stroke in a Child with Homozygous SS Sickle Cell Disease Associated with Cerebral Palsy: A Case Report. European Scientific Journal, ESJ, 21(33), 59. https://doi.org/10.19044/esj.2025.v21n33p59
Section
ESJ Natural/Life/Medical Sciences